Microcap Ledger

Tickers · $ELAB

PMGC Holdings Inc. $ELAB

By Microcap Ledger desk · CIK 0001840563

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Pharmaceutical Preparations
Headquarters
Newport Beach, CA
Fiscal year end
December 31
Shares outstanding
8,095,793 [10-Q 2026-08-14]
as of 2026-08-14

Sources: [10-K 2026-03-30]

What the company doesAI summary of filing

PMGC Holdings Inc. is a diversified holding company that owns four wholly owned subsidiaries: Northstrive Biosciences, a clinical-stage biopharmaceutical company developing engineered probiotic candidates (EL-22 and EL-32) for muscle preservation in obesity treatment; PMGC Capital, a multi-strategy investment vehicle; Pacific Sun Packaging, which manufactures custom protective packaging for IT hardware components; and AGA Precision Systems, a CNC machine shop providing high-tolerance machining and mold manufacturing for aerospace, defense, and industrial customers. The company generates revenue from its packaging and precision manufacturing operations while advancing clinical-stage biotechnology assets through Northstrive Biosciences and deploying capital through PMGC Capital. [10-K 2026-03-30]

Segments: Northstrive Biosciences (Clinical-stage biotechnology), PMGC Capital (Investment and capital deployment), Pacific Sun Packaging (IT hardware packaging), AGA Precision Systems (Precision manufacturing)

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$1.99M−$7.91M −$4.97M$18.14M[10-Q 2026-08-14]
FY ended Dec 2025$590.1K−$7.75M −$5.93M$5.40M[10-K 2026-03-30]
FY ended Dec 2024—−$6.25M −$5.49M$3.98M[10-K 2026-03-30]
Quarterly cash burn
−$2.48M
Cash runway Estimate
~21.9 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-13517,661,269[10-Q 2024-11-14]
2025-03-26707,106[10-K 2025-03-28]
2025-05-131,375,385[10-Q 2025-05-14]
2025-08-121,484,827[10-Q 2025-08-13]
2025-11-10744,121[10-Q 2025-11-14]
2026-03-301,159,112[10-K 2026-03-30]
2026-05-144,543,751[10-Q 2026-05-15]
2026-08-148,095,793[10-Q 2026-08-14]
Shelf registration
S-1 filed 2025-10-16; declared effective 2025-12-01 [S-1 2025-10-16]

Listing status

Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-04-07. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2025-04-078-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2025-04-07]

More on deficiency notices and uplistings: Listing status desk.

Catalysts and calendar

Facts as of . Small caps move fast; check the latest filings.